Align Wins China Patent Case Against Angelalign in Extraction-Gap Closure Dispute
Event summary
- Jinan Intermediate People's Court ruled Angelalign infringed Align’s extraction-gap-closure patent (CN113693748B) in China.
- Court ordered Angelalign to cease using the patented technology and pay RMB 10 million ($1.4M) in damages.
- Angelalign may appeal the decision; deadline for filing an appeal has not yet expired.
- Align also pursuing additional patent infringement actions against Angelalign affiliates in China and Europe.
The big picture
This victory reinforces Align’s intellectual property dominance in the clear aligner space, particularly in China, where it has made significant long-term investments. The ruling comes amid broader patent disputes between the two companies globally, highlighting the strategic importance of IP protection in the competitive dental technology sector.
What we're watching
- Appeal Outcome
- Whether Angelalign will appeal the ruling and how it may impact Align’s enforcement strategy.
- Global Enforcement
- The pace at which Align can secure similar rulings in other jurisdictions against Angelalign affiliates.
- Market Impact
- How this ruling will affect Angelalign’s operations and market share in China, a key growth region for clear aligners.